Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
2.
Shock ; 5(3): 213-6, 1996 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8696986

RESUMEN

Porcine hypodynamic shock was induced by continuous infusion of 5 micrograms lipopolysaccharide/kg per hour. This resulted in a decrease of cardiac output from baseline values of 3.5 +/- .9 L/min to 1.5 +/- .8 L/min and a reduced left ventricular stroke work index in the endotoxin-group (n = 6 animals). Pretreatment with the H1-antagonist dimethindene (2 mg/kg) in a second group (n = 6) significantly prevented these effects. Furthermore animals pretreated with the H1-antagonist showed a stable mean arterial blood pressure, whereas the control endotoxin-treated group revealed a drastic reduction in mean arterial blood pressure (99 +/- 4.7 mmHg versus 65.8 +/- 10 mmHg after 240 min, respectively). Pulmonary function and systemic vascular resistance were not ameliorated by the H1-antagonist in hypodynamic shock. Gastrointestinal mucosal pH (pHi), which indicates oxygenation of the mucosa, was decreased by endotoxin-infusion (7.45 +/- .32 baseline value to 6.92 +/- .24 after 120 min). This parameter as well as base excess values and lactate levels were significantly improved by dimethindene-pretreatment (p < .05). These results may indicate a beneficial effect of H1-antagonist-pretreatment on endotoxin-induced deterioration of the microcirculation. Furthermore our results clearly demonstrated that only pretreatment before endotoxemia with H1-antagonism is effective, since infusion of H1-antagonist in hypodynamic shock 45 min after addition of endotoxin (n = 6 animals) did not improve the cardiovascular system or the microcirculation.


Asunto(s)
Gasto Cardíaco Bajo/tratamiento farmacológico , Antagonistas de los Receptores Histamínicos H1/farmacología , Hipocinesia/tratamiento farmacológico , Mucosa Intestinal/efectos de los fármacos , Choque Séptico/tratamiento farmacológico , Animales , Presión Sanguínea/efectos de los fármacos , Gasto Cardíaco Bajo/inducido químicamente , Gasto Cardíaco Bajo/metabolismo , Frecuencia Cardíaca/efectos de los fármacos , Concentración de Iones de Hidrógeno , Hipocinesia/inducido químicamente , Hipocinesia/metabolismo , Mucosa Intestinal/metabolismo , Enfermedades Pulmonares/inducido químicamente , Enfermedades Pulmonares/tratamiento farmacológico , Enfermedades Pulmonares/metabolismo , Masculino , Microcirculación/efectos de los fármacos , Choque Séptico/inducido químicamente , Choque Séptico/metabolismo , Porcinos , Factor de Necrosis Tumoral alfa/metabolismo
3.
Shock ; 3(6): 416-21, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7656065

RESUMEN

The definite role of histamine in early hyperdynamic septic shock is not yet clear. Therefore a randomized, controlled, blind trial was performed to investigate the effect of the H1-antagonist dimethindene in hyperdynamic porcine shock. Lipopolysaccharide (LPS) infusion (5 micrograms/kg/h) in anesthetized pigs (n = 6) in the control-group induced a hyperdynamic shock state with a decrease in mean arterial blood pressure, and systemic vascular resistance (SVR), and an increase in mean arterial pulmonary pressure and pulmonary vascular resistance (PVR). In the verum group (n = 6) dimethindene (2 mg/kg) administered 15 min before LPS application prevented the decrease in SVR significantly (p < .05) and ameliorated the increase in MPAP and PVR. The impairment in pulmonary function, as measured by the oxygenation ratio (PaO2/FiO2) in LPS-treated animals, was reduced by the H1-antagonist (p = .01). Tissue oxygenation was ameliorated by the H1-antagonist treatment, as demonstrated by plasma lactate levels and base excess values (p < .05, control group versus dimethindene group). The increase in tumor necrosis factor alpha by LPS infusion was not influenced by H1-antagonist pretreatment. The early decrease in SVR did not correlate with an enhanced nitric oxide formation, as measured by nitrate/nitrite plasma levels.


Asunto(s)
Dimetindeno/farmacología , Receptores Histamínicos H1/metabolismo , Choque Séptico/metabolismo , Animales , Femenino , Lipopolisacáridos , Circulación Pulmonar/efectos de los fármacos , Choque Séptico/inducido químicamente , Choque Séptico/prevención & control , Análisis de Supervivencia , Porcinos , Factor de Necrosis Tumoral alfa/análisis , Resistencia Vascular/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA